A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
NCT02057341
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
LMNA-Related Dilated Cardiomyopathy
Interventions
DRUG:
ARRY-371797, p38 inhibitor; oral
Sponsor
Pfizer